Regulation of self-ligands for activating natural killer cell receptors

Annals of Medicine

Volumn 45, Issue 4, 2013, Pages 384-394

  Lam, Runyi A ^a,b   Chwee, Jyh Y ^a,b   Le Bert, Nina ^a   Sauer, Maike ^c   Pogge Von Strandmann, Elke ^c   Gasser, Stephan ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cancer; Dnam 1; Infection; Innate immunity; Ncr; Nkg2d; Nkp80

Indexed keywords

ATR PROTEIN; CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; NKP65 LIGAND; NKP80 LIGAND; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; BACTERIAL INFECTION; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL STIMULATION; DENDRITIC CELL; DNA REPAIR; EPITHELIUM CELL; EXOSOME; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; IMMUNOGLOBULIN GENE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, NATURAL KILLER CELL;

EID: 84878533297     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2013.792495     Document Type: Review

References (199)

1. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity?-example of natural killer cells. Science. 2011; 331: 44-9.
2. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008; 9: 503-10.
3. Karre K. Natural killer cell recognition of missing self. Nat Immunol. 2008; 9 : 477 -80.
4. Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology. 2007; 121: 439-47.
5. Raulet D. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003; 3: 781-90.
6. Eagle RA, Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat Rev Immunol. 2007; 7: 737-44.
7. Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH. R AE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J Exp Med. 2012; 209: 2409-22.
8. Rabinovich B, Li J, Shannon J, H urren R, C halupny J, C osman D, et a l. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol. 2003; 170: 3572-6.
9. Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol. 2007; 178 : 961 -9.
10. Gasser S, Orsulic S, Brown EJ, Raulet DH.-DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005; 436 : 1186 -90.
11. Gasser S, Raulet D.-DNA damage response, immunity and cancer. Semin Cancer Biol. 2006; 16: 344-7.
12. Gasser S, Raulet DH.-DNA damage response arouses the immune system. Cancer Res. 2006; 66: 3959-62.
13. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 2007; 110: 606-15.
14. Soriani A, Z ingoni A, C erboni C, I annitto M L, R icciardi M R, D i Gialleonardo V, et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009; 113: 3503-11.
15. Bartkova J, Horejsi Z, Koed K, Kr ä mer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005; 434: 864-70.
16. Gorgoulis V, Vassiliou L, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005; 434 : 907 -13.
17. Bartek J, F alck J, L ukas J. C HK2 kinase-a busy messenger. N at Rev Mol Cell Biol. 2001 ; 2 : 877 -86.
18. Heinemann A, P aschen A. T umor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D. Oncoimmunology. 2012; 1: 535-6.
19. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol. 2008; 9 : 1065 -73.
20. H einemann A, Z hao F, P echlivanis S, E berle J, S teinle A, D iederichs S, et al. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res. 2012; 72: 460-71.
21. Tsukerman P, Stern-Ginossar N, Gur C, Glasner A, Nachmani D, Bauman Y, et al. MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res. 2012; 72 : 5463 -72.
22. Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J Immunol. 2009; 182: 39-43.
23. Routes J, Ryan S, Morris K, Takaki R, Cerwenka A, Lanier LL. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J Exp Med. 2005; 202: 1477-82.
24. Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, et al. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol. 2006; 176 : 5108 -16.
25. Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, et al. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. J Immunol. 2012; 188: 2136-45.
26. Liu XV, Ho SS, Tan JJ, Kamran N, Gasser S. Ras activation induces expression of raet1 family NK receptor ligands. J Immunol. 2012; 189 : 1826 -34.
27. Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev. 2006; 214: 130-42.
28. Salih HR, Rammensee HG, Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol. 2002; 169 : 4098 -102.
29. Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature. 2007; 447: 482-6.
30. Salih HR, Goehlsdorf D, Steinle A. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. Hum Immunol. 2006; 67: 188-95.
31. Waldhauer I, Goehlsdorf D, Gieseke F, Weinschenk T, Wittenbrink M, Ludwig A, et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008; 68: 6368-76.
32. Boutet P, Aguera-Gonzalez S, Atkinson S, Pennington CJ, Edwards DR, Murphy G, et al. Cutting edge: the metalloproteinase ADAM17/TNFalpha- converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J Immunol. 2009; 182 : 49 -53.
33. Liu G, Atteridge CL, Wang X et al.-membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J Immunol. 2010; 184 : 3346 -50.
34. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T- cell activation. Nature. 2002; 419 : 734 -8.
35. Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, et al. Evasion from NK cell immunity by MHC class I chainrelated molecules expressing colon adenocarcinoma. J Immunol. 2003; 171 : 6891 -9.
36. Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P, Janin A, et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A. 2002; 99 : 2977 -82.
37. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent eff ector function. Immunity. 2001; 15: 83-93.
38. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001; 2 : 255 -60.
39. Siren J, Sareneva T, Pirhonen J, Strengell M, Veckman V, Julkunen I, et al. Cytokine and contact-dependent activation of natural killer cells by infl uenza A or Sendai virus-infected macrophages. J Gen Virol. 2004; 85 : 2357 -64.
40. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008; 8: 259-68.
41. Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol. 2008; 20 : 30 -8.
42. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol. 2004; 172: 2001-5.
43. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, et al. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to infl uenza infection. J Immunol. 2007; 178: 2688-98.
44. Ebihara T, Masuda H, Akazawa T, Shingai M, Kikuta H, Ariga T, et al. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol. 2007; 19: 1145-55.
45. Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, et al. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009; 5: e1000613.
46. Norman JM, Mashiba M, McNamara LA, Onafuwa-Nuga A, Chiari-Fort E, Shen W, et al.-antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol. 2011; 12: 975-83.
47. Pham TN, Richard J, Gerard FC, Power C, Cohen É A. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates. J Virol. 2011; 85 : 12254 -61.
48. Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathog. 2011; 7: e1002265.
49. Stern-Ginossar N, E lefant N, Z immermann A, W olf D G, S aleh N, Biton M, et al. Host immune system gene targeting by a viral miRNA. Science. 2007; 317: 376-81.
50. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe. 2009; 5 : 376 -85.
51. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe. 2011; 9: 93-102.
52. Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol. 2003; 170: 1249-56.
53. Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol. 2006; 176: 905-13.
54. Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, et al. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-defi cient melanoma by natural killer cells. Int J Cancer. 2009; 124: 1594-604.
55. Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, et al. TGF-beta and metalloproteinases diff erentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain. 2006; 129 : 2416 -25.
56. Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, et al. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 2004; 64: 7596-603.
57. Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, et al. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol. 2004; 173 : 5583 -90.
58. Lin D, Lavender H, Soilleux EJ, O'Callaghan CA. NF-kappaB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem. 2012; 287: 4299-310.
59. Gannage M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L, et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft -versus-host disease. Transplantation. 2008; 85: 911 -15.
60. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996; 93 : 12445 -50.
61. Fionda C, Soriani A, Malgarini G, Iannitto ML, Santoni A, Cippitelli M. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. J Immunol. 2009; 183 : 4385 -94.
62. Nice TJ, Coscoy L, Raulet DH. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J Exp Med. 2009; 206 : 287 -98.
63. Nice TJ, Deng W, Coscoy L, Raulet DH. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase. J Immunol. 2010; 185: 5369-76.
64. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 1996; 4: 573-81.
65. Shibuya A, Lanier LL, Phillips JH. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol. 1998; 161: 1671-6.
66. Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, Shibuya A. Identifi cation and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun. 2005; 329: 996-1000.
67. Chen L, Xie X, Zhang X, Jia W, Jian J, Song C, et al.-expression, regulation and adhesion function of a novel CD molecule, CD226, on human endothelial cells. Life Sci. 2003; 73: 2373-82.
68. Seth S, Georgoudaki AM, Chambers BJ, Qiu Q, Kremmer E, Maier MK, et al. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. J Leukoc Biol. 2009; 86: 91-101.
69. Shibuya K, Shirakawa J, Kameyama T, Honda S, Tahara-Hanaoka S, Miyamoto A, et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell diff erentiation and proliferation. J Exp Med. 2003; 198: 1829-39.
70. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, Honda S, et al. Accelerated tumor growth in mice defi cient in DNAM-1 receptor. J Exp Med. 2008; 205: 2959-64.
71. Chan CJ, Andrews DM, McLaughlin NM, Yagita H, Gilfi llan S, Colonna M, et al. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases. J Immunol. 2010; 184: 902-11.
72. Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res. 2004; 64: 9180-4.
73. Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, et al. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood. 2005; 105: 2066-73.
74. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, et al. Identifi cation of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 2003; 198: 557-67.
75. Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, Rivera P, et al. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol Immunol. 2005; 42: 463-9.
76. Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, Miyamoto A, et al. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/ CD112). Int Immunol. 2004; 16: 533-8.
77. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989; 56 : 855 -65.
78. Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, et al.-poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 1990; 9: 3217-24.
79. Eberle F, Dubreuil P, Mattei MG, Devilard E, Lopez M.-human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene. 1995; 159: 267-72.
80. Shmueli O, Horn-Saban S, Chalifa-Caspi V, Shmoish M, Ophir R, Benjamin-Rodrig H, et al. GeneNote: whole genome expression profi les in normal human tissues. C R Biol. 2003; 326: 1067-72.
81. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, et al.-requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 2007; 67 : 8444 -9.
82. Carlsten M, Bjorkstrom NK, Norell H, Bryceson Y, van Hall T, Baumann BC, et al. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 2007; 67: 1317-25.
83. Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A, et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood. 2006; 107: 2030-6.
84. Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, et al. Loss of DNAM-1 contributes to CD8 T-cell exhaustion in chronic HIV-1 infection. Eur J Immunol. 2010; 40 : 949 -54.
85. Y. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fi broblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway. Oncogene. 2005; 24: 2229-35.
86. Lui W-Y, Sze K-L, Lee WM. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families. J Cell Physiol. 2006; 207 : 144 -57.
87. Solecki D, Wimmer E, Lipp M, Bernhardt G. Identifi cation and characterization of the cis-acting elements of the human CD155 gene core promoter. J Biol Chem. 1999; 274 : 1791 -800.
88. Toft gard R. Hedgehog signalling in cancer. Cell Mol Life Sci. 2000; 57 : 1720 -31.
89. Solecki D J, G romeier M, M ueller S, B ernhardt G, W immer E. Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog. J Biol Chem. 2002; 277: 25697-702.
90. Ardolino M, Zingoni A, Cerboni C, Cecere F, Soriani A, Iannitto ML, et al. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood. 2011; 117: 4778-86.
91. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair. 2004; 3: 1109-15.
92. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science. 2010; 330: 517-21.
93. Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, et al. Estrogen-induced mitochondrial reactive oxygen species as signaltransducing messengers. Biochemistry. 2005; 44: 6900-9.
94. Solecki D, Bernhardt G, Lipp M, Wimmer E. Identifi cation of a nuclear respiratory factor-1 binding site within the core promoter of the human polio virus receptor/CD155 gene. J Biol Chem. 2000; 275 : 12453 -62.
95. Kamran N, Takai Y, Miyoshi J, Biswas SK, Wong JS, Gasser S. Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells. PLoS One. 2013; 8: e54406.
96. Andersen J, VanScoy S, Cheng TF, Gomez D, Reich NC. IRF-3-dependent and augmented target genes during viral infection. Genes Immun. 2008; 9 : 168 -75.
97. Pappworth IY, Wang EC, Rowe M.-switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol. 2007; 81: 474-82.
98. Magri G, Muntasell A, Romo N, S á ez-Border í as A, Pende D, Geraghty DE, et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood. 2011; 117 : 848 -56.
99. Van De Stolpe A, Van Der Saag PT., Intercellular adhesion molecule-1, J Mol Med (Berl), 1996, 74, 13-33
100. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986 ; 137 : 1270-4.
101. Marlin SD, Springer TA. Purifi ed intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 1987 ; 51 : 813-19.
102. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988; 52: 925-33.
103. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989; 83: 2008-17.
104. Gaglia JL, Greenfi eld E A, M attoo A , S harpe A H, F reeman G J, Kuchroo VK. Intercellular adhesion molecule 1 is critical for activation of CD28-defi cient T cells. J Immunol. 2000; 165: 6091-8.
105. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 1989; 337: 181-4.
106. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al. Th e immunological synapse: a molecular machine controlling T cell activation. Science. 1999; 285: 221-7.
107. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol. 2004; 173: 3653-9.
108. Choi YL, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, et al. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem. 2004; 52: 591-601.
109. Hemmerlein B, Scherbening J, Kugler A, Radzun HJ. Expression of VCAM-1, ICAM-1, E- and P-selectin and tumour-associated macrophages in renal cell carcinoma. Histopathology. 2000; 37: 78-83.
110. Lin YC, Shun CT, Wu MS, Chen CC. A novel anticancer eff ect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factorkappaB. Clin Cancer Res. 2006; 12: 7165-73.
111. Tempia-Caliera A A, H orvath L Z, Z immermann A , T ihanyi T T, Korc M, Friess H, et al. Adhesion molecules in human pancreatic cancer. J Surg Oncol. 2002; 79: 93-100.
112. Hayes SH, Seigel GM. Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues. Int J Clin Exp Pathol. 2009; 2: 553-60.
113. Basoglu M, Atamanalp SS, Yildirgan MI, Aydinli B, Ozturk G, Akcay F, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007 ; 39 : 136-40.
114. Dowlati A, Gray R, Sandler AB, Schiller JH, Johnson DH. Cell adhesion molecules, vascular endothelial growth factor, and basic fi broblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group Study. Clin Cancer Res. 2008 ; 14 : 1407-12.
115. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis. 2005 ; 26 : 943-50.
116. Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F. LFA-1 and ICAM-1 expression induced during melanoma- endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro. BMC Cancer. 2012; 12, 455.
117. Dong C, Slattery MJ, Liang S, Peng HH. Melanoma cell extravasation under fl ow conditions is modulated by leukocytes and endogenously produced interleukin 8. Mol Cell Biomech. 2005 ; 2 : 145-59.
118. Gorgoulis VG, Zacharatos P, Kotsinas A, Kletsas D, Mariatos G, Zoumpourlis V , et al. p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J. 2003; 22: 1567-78.
119. Gorgoulis VG, Pratsinis H, Zacharatos P, Demoliou C, Sigala F, Asimacopoulos PJ , et al. p53-dependent ICAM-1 overexpression in senescent human cells identifi ed in atherosclerotic lesions. Lab Invest. 2005 ; 85 : 502-11.
120. Kletsas D, Pratsinis H, Mariatos G, Zacharatos P, Gorgoulis VG. Th e proinfl ammatory phenotype of senescent cells: the p53-mediated ICAM-1 expression. Ann N Y Acad Sci. 2004; 1019: 330-2.
121. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule- 1 (CD54) gene expression. J Leukoc Biol. 1999; 66: 876-88.
122. Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS. Essential role of cooperative NF-kappaB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiationinduced invasion and migration in glioma. Oncogene. 2012 Nov 26 [Epub ahead of print].
123. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem. 1999 ; 274 : 9707-20.
124. Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation. 1999 ; 67 : 137-44.
125. Harcourt BH, Rota PA, Hummel KB, Bellini WJ, Off ermann MK. Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol. 1999 ; 57 : 9-16.
126. Owen SM, Rudolph DL, Dezzutti CS, Shibata N, Naik S, Caughman SW , et al. Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element. AIDS Res Hum Retroviruses. 1997; 13: 1429-37.
127. Shrikant P, Benos DJ, Tang LP, Benveniste EN. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol. 1996 ; 156 : 1307-14.
128. Hu KQ, Yu CH, Vierling JM. Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci U S A. 1992 ; 89 : 11441-5.
129. Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ. Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J Biol Chem. 1997 ; 272 : 28582-9.
130. Chini BA, Fiedler MA, Milligan L, Hopkins T, Stark JM. Essential roles of NF-kappaB and C/EBP in the regulation of intercellular adhesion molecule-1 aft er respiratory syncytial virus infection of human respiratory epithelial cell cultures. J Virol. 1998; 72: 1623-6.
131. Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986; 137: 245-54.
132. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R , et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986; 137: 1893-6.
133. Jahnke A, Johnson JP. Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. Immunobiology. 1995; 193: 305-14.
134. Shrikant P, Chung IY, Ballestas ME, Benveniste EN. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J Neuroimmunol. 1994; 51: 209-20.
135. Kim JD , Lee JL , Park JH , Lee JM , Kim YH , Kim SJ. Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines. Yonsei Med J. 1995; 36: 15-25.
136. Jobin C, Hellerbrand C, Licato LL, Brenner DA, Sartor RB. Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut. 1998 ; 42 : 779-87.
137. Cobb RR, Felts KA, Parry GC, Mackman N. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without aff ecting nuclear translocation of nuclear factor-kappa B. Eur J Immunol. 1996; 26: 839-45.
138. Look A T. O ncogenic role of "master" transcription factors in human leukemias and sarcomas: a developmental model. Adv Cancer Res. 1995 ; 67 : 25-57.
139. Song S, Ling-Hu H, Roebuck KA, Rabbi MF, Donnelly RP, Finnegan A. Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood. 1997; 89: 4461-9.
140. Kooy AJ, Prens EP, Van Heukelum A, Vuzevski VD, Van Joost T, Tank B. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10? J Pathol. 1999; 187: 351-7.
141. Shrikant P, Lee SJ, Kalvakolanu I, Ransohoff RM, Benveniste EN. Stimulus-specifi c inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta. J Immunol. 1996; 157: 892-900.
142. Shrikant P, Weber E, Jilling T, Benveniste EN. Intercellular adhesion molecule-1 gene expression by glial cells. Diff erential mechanisms of inhibition by IL-10 and IL-6. J Immunol. 1995; 155: 1489-501.
143. Renkonen R, Mattila P, Majuri ML, Paavonen T, Silvennoinen O. IL-4 decreases IFN-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism. Scand J Immunol. 1992; 35: 525-30.
144. Joyce MG, Tran P, Zhuravleva MA, Jaw J, Colonna M, Sun PD. Crystal structure of human natural cytotoxicity receptor NKp30 and identifi cation of its ligand binding site. Proc Natl Acad Sci U.S.A. 2011 ; 108 : 6223-8.
145. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. Identifi cation and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999; 190: 1505-16.
146. Delahaye N F, R usakiewicz S , M artins I , M é n ard C , R oux S , L yonnet L , et al. Alternatively spliced NKp30 isoforms aff ect the prognosis of gastrointestinal stromal tumors. Nat Med. 2011; 17: 700-7.
147. Hollyoake M, Campbell RD, Aguado B. NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli. Mol Biol Evol. 2005 ; 22 : 1661-72.
148. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. Th e B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med. 2009 ; 206 : 1495-503.
149. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP , et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 2007; 27: 965-74.
150. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. HLAB- associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev. 2007; 21: 848-61.
151. Grover A , I zzo A A. B AT3 regulates Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis of macrophages. PLoS One. 2012 ; 7 : e40836.
152. Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol. 2011; 187: 5693-702.
153. Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, Nohroudi K, et al. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One. 2008; 3: e3377.
154. Kamper N, Franken S, Temme S, Koch S, Bieber T, Koch N. gamma-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. FASEB J. 2012; 26: 104-16.
155. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol. 2005; 6: 515-23.
156. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A , et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 1999; 189: 787-96.
157. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E , et al. NKp44, a novel triggering surface molecule specifi cally expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 1998; 187: 2065-72.
158. Hecht ML , Rosental B , Horlacher T , Hershkovitz O , De Paz JL , Noti C , et al. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to diff erent heparan sulfate/heparin sequences. J Proteome Res. 2009 ; 8 : 712-20.
159. Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, Bar-Ilan A, et
160. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol. 2009 ; 10 : 148-55.
161. Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, Colone M , et al. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun. 2008 ; 76 : 1719-27.
162. Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 2009; 183: 2610-21.
163. Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, et al. Activation of natural killer cells by newcastle disease virus hemagglutinin- neuraminidase. J Virol. 2009; 83: 8108-21.
164. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol. 2001; 31: 2680-9.
165. Vieillard V, Strominger JL, Debre P. NK cytotoxicity against CD4- T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A. 2005; 102: 10981-6.
166. Vieillard V, Dereuddre-Bosquet N, Mangeot-Mederle I, Le Grand R, Debr é P. An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques. Vaccine. 2012; 30: 6883-91.
167. Madrid AS, Ganem D. Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J Virol. 2012; 86: 8693-704.
168. De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, Mavilio D, et al. Th e impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol. 2003 ; 33 : 2410-18.
169. P essino A , S ivori S , B ottino C , M alaspina A , M orelli L , M oretta L , et a l. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 1998 ; 188 : 953-60.
170. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, et al. p46, a novel natural killer cell-specifi c surface molecule that mediates cell activation. J Exp Med. 1997; 186: 1129-36.
171. Jaron-Mendelson M, Yossef R, Appel MY, Zilka A, Hadad U, Afergan F , et al. Dimerization of NKp46 receptor is essential for NKp46-mediated lysis: characterization of the dimerization site by epitope mapping. J Immunol. 2012; 188: 6165-74.
172. Bloushtain N, Qimron U, Bar-Ilan A, Hershkovitz O, Gazit R, Fima E, et al. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol. 2004 ; 173 : 2392-401.
173. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001; 409: 1055-60.
174. Jarahian M, Fiedler M, Cohnen A, Djandji D, H ä mmerling GJ, Gati C , et al. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 2011; 7 : e1002195.
175. Nanda JS, et al. Vimentin expressed on Mycobacterium tuberculosis- infected human monocytes is involved in binding to the NKp46 receptor. J Immunol. 2006 ; 177 : 6192-8.
176. Mavoungou E, Held J, Mewono L, Kremsner PG. A Duff y binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum- parasitized erythrocytes by natural killer cells. J Infect Dis. 2007; 195: 1521-31.
177. Spreu J, Kuttruff S, Stejfova V, Dennehy KM, Schittek B, Steinle A. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proc Natl Acad Sci U S A. 2010; 107: 5100-5.
178. Vitale M, Falco M, Castriconi R, Parolini S, Zambello R, Semenzato G, et al. Identifi cation of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol. 2001; 31: 233-42.
179. Dennehy KM, Klimosch SN, Steinle A. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. J Immunol. 2011; 186 : 657-61.
180. Welte S, Kuttruff S , W aldhauer I , S teinle A. M utual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol. 2006; 7: 1334-42.
181. Akatsuka A, Ito M, Yamauchi C, Ochiai A, Yamamoto K, Matsumoto N. Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1. Int Immunol. 2010; 22: 783-90.
182. Th omas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, et al. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A. 2008 ; 105 : 1656-61.
183. Sancar A, Lindsey-Boltz LA, Unsal-Kaccmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004; 73: 39-85.
184. Halazonetis TD. Constitutively active DNA damage checkpoint pathways as the driving force for the high frequency of p53 mutations in human cancer. DNA Repair (Amst). 2004; 3: 1057-62.
185. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifi er of carcinogenesis. Cell. 2007; 130: 1005-18.
186. Lee YJ, Lee HJ, Lee JS, Jeoung D, Kang CM, Bae S, et al. A novel function for HSF1-induced mitotic exit failure and genomic instability through direct interaction between HSF1 and Cdc20. Oncogene. 2008 ; 27 : 2999-3009.
187. Tang D, Khaleque MA, Jones EL, Th eriault JR, Li C, Wong WH, et al. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005; 10: 46-58.
188. Popa N, Cedile O, Pollet-Villard X, Bagnis C, Durbec P, Boucraut J. RAE-1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres. Glia. 2011; 59: 35-44.
189. Nomura M, Takihara Y, Shimada K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein. Diff erentiation. 1994 ; 57 : 39-50.
190. Zou Z, Nomura M, Takihara Y, Yasunaga T, Shimada K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J Biochem. 1996; 119: 319-28.
191. Whang M, Guerra N, Raulet D. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifi cally in the skin. J Immunol. 2009; 182: 4557-64.
192. Tang KF, He CX, Zeng GL, Wu J, Song GB, Shi YS, et al. Induction of MHC class I-related chain B (MICB) by 5-aza-2 ' -deoxycytidine. Biochem Biophys Res Commun. 2008; 370: 578-83.
193. Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res. 2011; 71: 5998-6009.
194. Aoudjit F, Brochu N, Morin N, Poulin G, Stratowa C, Audette M. Heterodimeric retinoic acid receptor-beta and retinoid X receptoralpha complexes stimulate expression of the intercellular adhesion molecule-1 gene. Cell Growth Diff er. 1995; 6: 515-21.
195. S aklatvala J , D avis W , G uesdon F. I nterleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction. Philos Trans R Soc Lond B Biol Sci. 1996; 351: 151-7.
196. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem. 1995 ; 270 : 30264-7.
197. Look DC, Pelletier MR, Holtzman MJ. Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem. 1994 ; 269 : 8952-8.
198. Caldenhoven E, Coff er P, Yuan J, Van de Stolpe A, Horn F, Kruijer W, et al. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J Biol Chem. 1994 ; 269 : 21146-54.
199. Caldenhoven E, van Dijk T, Raaijmakers JA, Lammers JW, Koenderman L, De Groot RP. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J Biol Chem. 1995 ; 270 : 25778-84.